Why Provation’s iPro Lite could signal the end of paper-based anesthesia workflows
Provation launches iPro Lite for mobile anesthesia documentation. Find out how it could change billing, compliance, and risk in outpatient surgery centers.
Can wearable ultrasound reinvent breast imaging? What the iSono Health ATUSA launch really signals
iSono Health launches ATUSA™, the first wearable breast ultrasound. Find out how it could transform access, accuracy, and economics in breast imaging.
FDA clears BEAR Implant label for lower osteoarthritis risk: What this changes in ACL surgery
FDA clears PTOA risk reduction claim for Miach Orthopaedics’ BEAR Implant. Find out what this means for ACL treatment, patients, and future adoption.
FDA clears VizMark’s VM1 tumor marker: Is this the fix for MRI artifact in breast imaging?
VizMark’s VM1 marker receives FDA clearance for artifact-free breast imaging. Find out how this may change tumor localization in dense breast cases.
What FDA breakthrough status for the Amplifi Vein Dilation System means for dialysis care in 2026
Amplifi Vascular’s device earns FDA Breakthrough and CMS Category B status. Find out what this means for dialysis access innovation and payer alignment.
Strive finalizes Semler Scientific acquisition to strengthen diagnostic and patient monitoring capabilities
Find out how Strive’s acquisition of Semler Scientific strengthens its diagnostic and patient monitoring capabilities in the regulated medical device market.
Why AIROS Medical’s extended warranty could reshape buyer expectations in lymphedema care
Find out how AIROS Medical’s five-year warranty on compression devices may shift durability standards and procurement expectations in lymphedema care.
GT Medical Technologies’ BRIDGES trial begins enrollment, testing GammaTile in newly diagnosed glioblastoma patients
GT Medical Technologies has announced the first patient enrollments in its BRIDGES trial, a randomized clinical study assessing the use of GammaTile therapy in newly diagnosed glioblastoma. The trial introduces GammaTile at the time of initial tumor resection, marking a notable shift from the conventional glioblastoma radiation timeline, which typically delays radiation until several weeks […]
Robotic cochlear implants approved for kids: Is iotaSOFT reshaping pediatric ENT standards?
iotaMotion, Inc. has received U.S. Food and Drug Administration 510(k) clearance to expand the approved use of its iotaSOFT Robotic-Assisted Cochlear Implant Insertion System for children as young as four years old. This regulatory milestone makes the iotaSOFT system the first robotic-assisted cochlear insertion platform authorized for use in school-aged pediatric patients, expanding access to […]
Vista AI raises $29.5m to expand automated MRI scanning beyond cardiology
Vista AI, a U.S.-based medical imaging software company specializing in AI-powered MRI automation, has raised $29.5 million in Series B financing to accelerate its product roadmap and scale adoption across U.S. hospitals and imaging centers. The funding round, announced on January 14, 2026, includes strategic investments from leading health systems such as Cedars-Sinai Health System, […]